Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase III study of vericiguat in worsening chronic heart failure meets primary endpoint

Nov. 20, 2019

COR-001 suppresses hsCRP in patients with chronic kidney disease

Nov. 20, 2019

DWP-212525, a next-generation therapeutic for autoimmune diseases

Nov. 20, 2019

Celldex begins phase Ia study with KIT inhibitor CDX-0159

Nov. 20, 2019

Haplodeficiency disrupts microglial responses in AD models

Nov. 20, 2019

RQ-00490721 prevents cardiac dysfunction in mouse model of heart failure

Nov. 20, 2019

Seviprotimut-L demonstrates safety and efficacy in part B1 of MAVIS phase III study

Nov. 20, 2019

Novel prostate cancer bone metastasis model in humanized mice

Nov. 20, 2019

Positive data presented for WP-1220 in patients with CTCL

Nov. 20, 2019

Novel potent OXE receptor antagonists with prolonged plasma lifetime for eosinophilic diseases

Nov. 20, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...